Strong Franc Drags Down Drug Company Performance

BMI View: Despite the massive appreciation of the Swiss franc against the euro and the dollar through 2010 - and with the trend continuing into 2011 - we believe the high value-added nature of Swiss pharmaceutical exports, particularly pharmaceuticals, will ensure that external demand for the country's goods does not suffer an outright collapse and continues to support the wider economy.

To read the full article, please choose one of the following options: